img

Global SPECT Radiopharmaceuticals Market Segment Research Report 2024

Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global SPECT Radiopharmaceuticals Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global SPECT Radiopharmaceuticals Market Segment Research Report 2022》, which aims to sort out the development status and trends of the SPECT Radiopharmaceuticals industry at home and abroad, estimate the overall market scale of the SPECT Radiopharmaceuticals industry and the market share of major countries, SPECT Radiopharmaceuticals industry, and study and judge the downstream market demand of SPECT Radiopharmaceuticals through systematic research, Analyze the competition pattern of SPECT Radiopharmaceuticals, so as to help solve the pain points of various stakeholders in SPECT Radiopharmaceuticals industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of SPECT Radiopharmaceuticals Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in SPECT Radiopharmaceuticals Market?
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer Healthcare (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Major Type of SPECT Radiopharmaceuticals Covered in XYZResearch report
Tc-99
Tl-201
Ga-67
I-123
Others
Application Segments Covered in XYZResearch Market
Diagnostics
Therapeutics

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global SPECT Radiopharmaceuticals Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global SPECT Radiopharmaceuticals Market by Value
2.2.1 Global SPECT Radiopharmaceuticals Revenue by Type
2.2.2 Global SPECT Radiopharmaceuticals Market by Value (%)
2.3 Global SPECT Radiopharmaceuticals Market by Production
2.3.1 Global SPECT Radiopharmaceuticals Production by Type
2.3.2 Global SPECT Radiopharmaceuticals Market by Production (%)

3. The Major Driver of SPECT Radiopharmaceuticals Industry
3.1 Historical & Forecast Global SPECT Radiopharmaceuticals Demand
3.2 Largest Application for SPECT Radiopharmaceuticals (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional SPECT Radiopharmaceuticals Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of SPECT Radiopharmaceuticals Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia SPECT Radiopharmaceuticals Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global SPECT Radiopharmaceuticals Average Price Trend
12.1 Market Price for Each Type of SPECT Radiopharmaceuticals in US (2018-2022)
12.2 Market Price for Each Type of SPECT Radiopharmaceuticals in Europe (2018-2022)
12.3 Market Price for Each Type of SPECT Radiopharmaceuticals in China (2018-2022)
12.4 Market Price for Each Type of SPECT Radiopharmaceuticals in Japan (2018-2022)
12.5 Market Price for Each Type of SPECT Radiopharmaceuticals in India (2018-2022)
12.6 Market Price for Each Type of SPECT Radiopharmaceuticals in Korea (2018-2022)
12.7 Market Price for Each Type of SPECT Radiopharmaceuticals in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 SPECT Radiopharmaceuticals Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of SPECT Radiopharmaceuticals

14. SPECT Radiopharmaceuticals Competitive Landscape
14.1 Cardinal Health Inc. (U.S.)
14.1.1 Cardinal Health Inc. (U.S.) Company Profiles
14.1.2 Cardinal Health Inc. (U.S.) Product Introduction
14.1.3 Cardinal Health Inc. (U.S.) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Mallinckrodt plc (Ireland)
14.2.1 Mallinckrodt plc (Ireland) Company Profiles
14.2.2 Mallinckrodt plc (Ireland) Product Introduction
14.2.3 Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 GE Healthcare (U.K.)
14.3.1 GE Healthcare (U.K.) Company Profiles
14.3.2 GE Healthcare (U.K.) Product Introduction
14.3.3 GE Healthcare (U.K.) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Lantheus Medical Imaging, Inc. (U.S.)
14.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profiles
14.4.2 Lantheus Medical Imaging, Inc. (U.S.) Product Introduction
14.4.3 Lantheus Medical Imaging, Inc. (U.S.) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Bayer Healthcare (Germany)
14.5.1 Bayer Healthcare (Germany) Company Profiles
14.5.2 Bayer Healthcare (Germany) Product Introduction
14.5.3 Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Bracco Imaging S.p.A (Italy)
14.6.1 Bracco Imaging S.p.A (Italy) Company Profiles
14.6.2 Bracco Imaging S.p.A (Italy) Product Introduction
14.6.3 Bracco Imaging S.p.A (Italy) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Eczacibasi-Monrol Nuclear Products (Turkey)
14.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profiles
14.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Product Introduction
14.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Nordion, Inc. (Canada)
14.8.1 Nordion, Inc. (Canada) Company Profiles
14.8.2 Nordion, Inc. (Canada) Product Introduction
14.8.3 Nordion, Inc. (Canada) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Advanced Accelerator Applications S.A. (France)
14.9.1 Advanced Accelerator Applications S.A. (France) Company Profiles
14.9.2 Advanced Accelerator Applications S.A. (France) Product Introduction
14.9.3 Advanced Accelerator Applications S.A. (France) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 IBA Molecular Imaging (Belgium)
14.10.1 IBA Molecular Imaging (Belgium) Company Profiles
14.10.2 IBA Molecular Imaging (Belgium) Product Introduction
14.10.3 IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of SPECT Radiopharmaceuticals Industry (Volume)
Figure 2. SPECT Radiopharmaceuticals Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by SPECT Radiopharmaceuticals Revenue in 2022
Figure 5. US SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia SPECT Radiopharmaceuticals Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. SPECT Radiopharmaceuticals Revenue, by Type (Million USD) (2018-2028)
Table 4. SPECT Radiopharmaceuticals Production, by Type (K Unit) (2018-2028)
Table 5. SPECT Radiopharmaceuticals Demand (K Unit) by Application (2018-2028)
Table 6. SPECT Radiopharmaceuticals Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top SPECT Radiopharmaceuticals Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia SPECT Radiopharmaceuticals Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of SPECT Radiopharmaceuticals in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Cardinal Health Inc. (U.S.) Profiles
Table 61. Cardinal Health Inc. (U.S.) SPECT Radiopharmaceuticals Product Introduction
Table 62. Cardinal Health Inc. (U.S.) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Cardinal Health Inc. (U.S.) Strategic initiatives
Table 64. Mallinckrodt plc (Ireland) Profiles
Table 65. Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Product Introduction
Table 66. Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Mallinckrodt plc (Ireland) Strategic initiatives
Table 68. GE Healthcare (U.K.) Profiles
Table 69. GE Healthcare (U.K.) SPECT Radiopharmaceuticals Product Introduction
Table 70. GE Healthcare (U.K.) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. GE Healthcare (U.K.) Strategic initiatives
Table 72. Lantheus Medical Imaging, Inc. (U.S.) Profiles
Table 73. Lantheus Medical Imaging, Inc. (U.S.) SPECT Radiopharmaceuticals Product Introduction
Table 74. Lantheus Medical Imaging, Inc. (U.S.) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Lantheus Medical Imaging, Inc. (U.S.) Strategic initiatives
Table 76. Bayer Healthcare (Germany) Profiles
Table 77. Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Product Introduction
Table 78. Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Bayer Healthcare (Germany) Strategic initiatives
Table 80. Bracco Imaging S.p.A (Italy) Profiles
Table 81. Bracco Imaging S.p.A (Italy) SPECT Radiopharmaceuticals Product Introduction
Table 82. Bracco Imaging S.p.A (Italy) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bracco Imaging S.p.A (Italy) Strategic initiatives
Table 84. Eczacibasi-Monrol Nuclear Products (Turkey) Profiles
Table 85. Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Product Introduction
Table 86. Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Eczacibasi-Monrol Nuclear Products (Turkey) Strategic initiatives
Table 88. Nordion, Inc. (Canada) Profiles
Table 89. Nordion, Inc. (Canada) SPECT Radiopharmaceuticals Product Introduction
Table 90. Nordion, Inc. (Canada) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Nordion, Inc. (Canada) Strategic initiatives
Table 92. Advanced Accelerator Applications S.A. (France) Profiles
Table 93. Advanced Accelerator Applications S.A. (France) SPECT Radiopharmaceuticals Product Introduction
Table 94. Advanced Accelerator Applications S.A. (France) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Advanced Accelerator Applications S.A. (France) Strategic initiatives
Table 97. IBA Molecular Imaging (Belgium) Profiles
Table 98. IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Product Introduction
Table 99. IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. IBA Molecular Imaging (Belgium) Strategic initiatives

Select User License

$4850 Single Licence
$5850 Enterprise Licence
$6850 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries